The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Potentially inappropriate medications and their association with frailty, unplanned hospitalizations, and mortality in patients with cancer treated in the national U.S. Veterans Affairs Healthcare System.
 
Jennifer La
Research Funding - Merck (Inst)
 
Tammy Hshieh
No Relationships to Disclose
 
Anahid Hamparsumian
No Relationships to Disclose
 
Robert Zwolinski
No Relationships to Disclose
 
Jameson Wood
No Relationships to Disclose
 
Mayuri Dharne
No Relationships to Disclose
 
J. Michael Gaziano
No Relationships to Disclose
 
Mary T. Brophy
No Relationships to Disclose
 
Nhan Do
No Relationships to Disclose
 
Nikhil C. Munshi
Stock and Other Ownership Interests - C4 Therapeutics; OncoPep; Raqia
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Amgen; BeiGene; Bristol-Myers Squibb; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Legend Biotech; Novartis; OncoPep; Pfizer; Sebia; Takeda
Patents, Royalties, Other Intellectual Property - Oncopep
 
Jane A. Driver
No Relationships to Disclose
 
Gregory A. Abel
Consulting or Advisory Role - Novartis
 
Nathanael Fillmore
Research Funding - Merck (Inst)
 
Clark DuMontier
Stock and Other Ownership Interests - Lilly